Belite Bio’s $36 Million IPO

Wilson Sonsini Goodrich & Rosati and O’Melveny advised Belite Bio on the deal. Belite Bio, Inc., a clinical-stage biopharmaceutical drug development company, announced the pricing of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Roblox’s Acquisition of Hamul

Wilson Sonsini Goodrich & Rosati advised Roblox on the deal. Roblox announced it has acquired Hamul, developer of video, voice, and sound overlay software designed to...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here